Shlomi Nachman
Fortune : 930 973 $ au 31/07/2026
Fortune : 930 973 $ au 31/07/2026
Shlomi Nachman currently works at Impulse Dynamics (USA), Inc., as Chairman from 2023, AtriCure, Inc., as Independent Director from 2024, and JenaValve Technology, Inc., as Director from 2023.
Mr. Nachman also formerly worked at Johnson & Johnson, as Company Group Chairman.
Mr. Nachman received his undergraduate degree from Israel Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATRICURE, INC. 0,05 % | 18/05/2026 | 24 655 ( 0,05 % ) | 930 973 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ATRICURE, INC. | Directeur/Membre du Conseil | 03/01/2024 |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets transapical transcatheter aortic valve implantation systems | Directeur/Membre du Conseil | 14/09/2023 |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Président | 19/09/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
AtriCure, Inc.
AtriCure, Inc. Medical SpecialtiesHealth Technology Manufactures surgical and medical instruments | Health Technology |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets transapical transcatheter aortic valve implantation systems | Health Technology |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Health Technology |
Israel Institute of Technology
Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national